Cargando…
The dilemma of denosumab: Salvage of a femoral head giant cell tumour
INTRODUCTION: Denosumab is a monoclonal RANKL antibody which has been shown to be highly effective in treating giant cell tumour (GCT) of bone. We report on its use as a neo-adjuvant agent to avoid morbid surgery for an adolescent. PRESENTATION OF CASE: We report a case of a15-year old female with a...
Autores principales: | Gaston, Czar Louie, Puls, Florian, Grimer, Robert John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245664/ https://www.ncbi.nlm.nih.gov/pubmed/25290381 http://dx.doi.org/10.1016/j.ijscr.2014.09.018 |
Ejemplares similares
-
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
por: Gaston, Czar Louie, et al.
Publicado: (2016) -
Saving a Child's Elbow Joint: A Novel Reconstruction for a Tumour of the Distal Humerus
por: Graci, Calogero, et al.
Publicado: (2015) -
'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab
por: Vaishya, Raju, et al.
Publicado: (2015) -
Radiological findings of denosumab treatment for giant cell tumours of bone
por: van Langevelde, Kirsten, et al.
Publicado: (2020) -
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
por: Engellau, Jacob, et al.
Publicado: (2018)